Literature DB >> 1878314

Inter and intraindividual variations in plasma cholinesterase activity and substance concentration in employees of an organophosphorus insecticide factory.

A Brock1.   

Abstract

During a period of 10 months, inter and intraindividual variations in plasma cholinesterase (ChE) activity were studied in 331 employees of an organophosphorus insecticide factory, and in 193 healthy volunteers without occupational exposure to known ChE inhibitors. Repeated (n = 6) measurements of ChE activity and ChE substance concentration were performed in 410 subjects. The study showed substantial intraindividual variations of ChE activity and ChE substance concentration (up to 40%) in the employees and in the reference group. When effects due to sex, ChE-1 phenotype, body weight, and height were considered, one subgroup of employees of the organophosphorus insecticide factory showed a significantly lower average ChE activity than other subgroups; as ChE substance concentrations were found to be proportionally decreased, it was concluded that the low ChE activity was unrelated to occupational exposure. A combined determination of ChE activity and ChE substance concentration is recommended as a rational diagnostic tool when an unexpected decrease of plasma ChE activity is registered in people joining organophosphorus insecticide health surveillance programmes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1878314      PMCID: PMC1035419          DOI: 10.1136/oem.48.8.562

Source DB:  PubMed          Journal:  Br J Ind Med        ISSN: 0007-1072


  16 in total

1.  Immunoreactive plasma cholinesterase (EC 3.1.1.8) substance concentration, compared with cholinesterase activity concentration and albumin: inter- and intra-individual variations in a healthy population group.

Authors:  A Brock
Journal:  J Clin Chem Clin Biochem       Date:  1990-11

2.  Plasma cholinesterase activity in a healthy population group with no occupational exposure to known cholinesterase inhibitors: relative influence of some factors related to normal inter- and intra-individual variations.

Authors:  A Brock; V Brock
Journal:  Scand J Clin Lab Invest       Date:  1990-06       Impact factor: 1.713

3.  Cholinesterase activity of human plasma after intramuscular diisopropyl fluorophosphonate (DFP).

Authors:  T MUNKNER; J MATZKE; A VIDEBAEK
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1961

4.  Scientific Review No. 5. Assay of cholinesterase in clinical chemistry.

Authors:  E Silk; J King; M Whittaker
Journal:  Ann Clin Biochem       Date:  1979-03       Impact factor: 2.057

5.  Effect of body mass and other factors on serum liver enzyme levels in men attending for well population screening.

Authors:  D Robinson; T P Whitehead
Journal:  Ann Clin Biochem       Date:  1989-09       Impact factor: 2.057

Review 6.  Desirable performance standards for clinical chemistry tests.

Authors:  C G Fraser
Journal:  Adv Clin Chem       Date:  1983       Impact factor: 5.394

7.  Incipient cholinesterase inhibition in volunteers ingesting monocrotophos or mevinphos for one month.

Authors:  M M Verberk
Journal:  Toxicol Appl Pharmacol       Date:  1977-11       Impact factor: 4.219

8.  Temporal intrapersonal physiological variability of cholinesterase activity in human plasma and erythrocytes.

Authors:  F R Sidell; A Kaminskis
Journal:  Clin Chem       Date:  1975-12       Impact factor: 8.327

9.  Complete amino acid sequence of human serum cholinesterase.

Authors:  O Lockridge; C F Bartels; T A Vaughan; C K Wong; S E Norton; L L Johnson
Journal:  J Biol Chem       Date:  1987-01-15       Impact factor: 5.157

10.  On the calculation of a "reference change" for comparing two consecutive measurements.

Authors:  E K Harris; T Yasaka
Journal:  Clin Chem       Date:  1983-01       Impact factor: 8.327

View more
  6 in total

1.  Repeatability and validity of a field kit for estimation of cholinesterase in whole blood.

Authors:  L London; M L Thompson; S Sacks; B Fuller; O M Bachmann; J E Myers
Journal:  Occup Environ Med       Date:  1995-01       Impact factor: 4.402

2.  Factors affecting inter-individual variation in human plasma cholinesterase activity: body weight, height, sex, genetic polymorphism and age.

Authors:  A Brock; V Brock
Journal:  Arch Environ Contam Toxicol       Date:  1993-01       Impact factor: 2.804

3.  Chlorpyrifos exposure and biological monitoring among manufacturing workers.

Authors:  C J Burns; D Garabrant; J W Albers; S Berent; B Giordani; S Haidar; R Garrison; R J Richardson
Journal:  Occup Environ Med       Date:  2006-03       Impact factor: 4.402

4.  Safety, pharmacokinetics, and pharmacodynamics of TV-1380, a novel mutated butyrylcholinesterase treatment for cocaine addiction, after single and multiple intramuscular injections in healthy subjects.

Authors:  Orit Cohen-Barak; Jacqueline Wildeman; Jeroen van de Wetering; Judith Hettinga; Petra Schuilenga-Hut; Aviva Gross; Shane Clark; Merav Bassan; Yossi Gilgun-Sherki; Boaz Mendzelevski; Ofer Spiegelstein
Journal:  J Clin Pharmacol       Date:  2015-01-12       Impact factor: 3.126

5.  Arylesterase phenotype-specific positive association between arylesterase activity and cholinesterase specific activity in human serum.

Authors:  Yutaka Aoki; Kathy J Helzlsouer; Paul T Strickland
Journal:  Int J Environ Res Public Health       Date:  2014-01-27       Impact factor: 3.390

6.  Association of Long-Term Pesticide Exposure and Biologic Parameters in Female Farm Workers in Tanzania: A Cross Sectional Study.

Authors:  Wilbert Bunini Manyilizu; Robinson Hammerton Mdegela; Rudovick Kazwala; Hezron Nonga; Mette Muller; Elisabeth Lie; Eystein Skjerve; Jan Ludvig Lyche
Journal:  Toxics       Date:  2016-09-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.